NSE filing, NSE: PFIZER. Summary written from the filing by ALFA Finder's alert engine.
Pfizer Ltd: key numbers
- Share price
- ₹3,734.40
- Market cap
- ₹17,084 Cr
- Revenue (annual)
- ₹2,520 Cr
- Net profit (annual)
- ₹722.4 Cr
- P/E (TTM)
- 23.2×Sector 46.1×
- Promoter holding
- 63.92%+0.00% QoQ
- FII holding
- 1.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pfizer Ltd
All →Pfizer Other Announcement
Pfizer Ltd has filed its quarterly shareholding pattern as per SEBI regulations. This is a routine compliance disclosure.
Pfizer Legal & Regulatory
Pfizer Limited received a penalty order of Rs. 1.26 Crore from the Income Tax department regarding transfer pricing. The company plans to appeal the order and expects no material financial impact.
- Value
- ₹1.26 Cr
- From
- Deputy / Additional Commissioner of Income tax Transfer Pricing
Pfizer Management Change
Pfizer Limited announced the resignation of Mr. Sharad Goswami, Senior Director – Policy & Public Affairs, effective from the close of business on September 25, 2026.
Pfizer Board Meeting Outcome
Pfizer Board approved discontinuation of Minipress XL effective September 7, 2026. The company will receive ₹131.38 Crore lump-sum payment from Pfizer Inc., USA.
- Value
- ₹131.4 Cr
Pfizer Annual General Meeting
Pfizer Limited held its 75th Annual General Meeting on July 28, 2026. The meeting covered the adoption of financial statements, dividend declaration, and auditor remuneration ratification.
Pfizer Q1 FY27 Results: Net Profit ₹204.5 Cr, Up 6.6% YoY
Pfizer Ltd reported revenue from operations of ₹653.2 Cr (+8.3% YoY) and net profit of ₹204.5 Cr (+6.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹204.5 Cr · +6.6% YoY
Other board meeting date announcements
All →M M Forgings Board Meeting Date
MM Forgings scheduled its Q2 FY27 board meeting for 5 November 2026 to approve unaudited standalone and consolidated results for the quarter ended 30 September 2026.
Gujarat Terce Laboratories Board Meeting Date
Gujarat Terce Laboratories will hold a board meeting on November 5, 2026 to consider unaudited standalone results for September 2026. The trading window stays closed until November 7, 2026.
Gautam Gems Board Meeting Date
Gautam Gems Ltd scheduled a board meeting for 3 Nov 2026 to approve Q2 FY27 standalone results. No financial figures or other material decisions are disclosed in this advance intimation.
Gujjubhai Industries Board Meeting Date
Gujjubhai Industries has scheduled its Board meeting for 4 November 2026. The agenda includes approval of unaudited Q1 and H1 FY27 financial results.
The Hi-Tech Gears Board Meeting Date
The Hi-Tech Gears Ltd has scheduled a Board meeting on November 4, 2026 to approve un-audited Q1 and H1 FY27 results. No financial figures are disclosed.
Cranex Board Meeting Date
Cranex Ltd scheduled a board meeting for 5 Nov 2026 to consider Q2 FY27 financial results. No monetary figures or decisions are disclosed in this advance notice.